Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322270
Status:
COMPLETED
Last Update Posted:
2008-08-15
First Post:
2006-05-03
Brief Title:
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
Sponsor:
ARCA Biopharma Inc
Organization:
ARCA Biopharma Inc
Study Overview
Official Title:
Phase 3 Multicenter Multinational Open-Label Study to Evaluate the Safety and Efficacy of Alfimeprase in Subjects With Occluded Central Venous Access Devices SONOMA-3
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety profile of alfimeprase as assessed by monitoring of adverse events serious adverse events and major bleeding events for up to 120 minutes following the instillation of study drug to an occluded central venous access device
Detailed Description:
Further study details as provided by Nuvelo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None